Paper28595014
Chelator-Free and Biocompatible Melanin Nanoplatform with Facile-Loading Gadolinium and Copper-64 for Bioimaging.
Hong SH and 9 others. Bioconjug Chem, 2017. Cited by 28 papers, by iCite.
Cite this record
ConductScience Library. Chelator-Free and Biocompatible Melanin Nanoplatform with Facile-Loading Gadolinium and Copper-64 for Bioimaging. Papers, record 28595014. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28595014
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Copper Radioisotopes | Major topic |
| Diagnostic Imaging | Major topic |
| Melanins | Major topic |
| Molecular Probes | Major topic |
| Nanoparticles | Major topic |
| Biocompatible Materials | |
| Chelating Agents | |
| Gadolinium | |
| Magnetic Resonance Imaging | |
| Positron-Emission Tomography |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| P50 CA114747 | NCI NIH HHS | United States | P50CA114747 | PubMed and NIH |
Source NIH RePORTER
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40015933 | Advancements in molecular imaging probes for precision diagnosis and treatment of prostate cancer. | J Zhejiang Univ Sci B | 2025 | https://conductscience.org/library/papers/40015933 | PubMed |
| 39839493 | Strategies for specific multimodal imaging of cancer-associated fibroblasts and applications in theranostics of cancer. | Mater Today Bio | 2025 | https://conductscience.org/library/papers/39839493 | PubMed |
| 39199714 | Physiological Roles of Eumelanin- and Melanogenesis-Associated Diseases: A Look at the Potentialities of Engineered and Microbial Eumelanin in Clinical Practice. | Bioengineering (Basel) | 2024 | https://conductscience.org/library/papers/39199714 | PubMed |
| 38161509 | Melanin/melanin-like nanoparticles: As a naturally active platform for imaging-guided disease therapy. | Mater Today Bio | 2023 | https://conductscience.org/library/papers/38161509 | PubMed |
| 36792796 | Transcellular Transport Behavior of the Intact Polymeric Mixed Micelles with Different Polymeric Ratios. | AAPS PharmSciTech | 2023 | https://conductscience.org/library/papers/36792796 | PubMed |
| 36402976 | Melanin-like nanoparticles: advances in surface modification and tumour photothermal therapy. | J Nanobiotechnology | 2022 | https://conductscience.org/library/papers/36402976 | PubMed |
| 36008707 | MC1R and melanin-based molecular probes for theranostic of melanoma and beyond. | Acta Pharmacol Sin | 2022 | https://conductscience.org/library/papers/36008707 | PubMed |
| 35159738 | Exogenous Contrast Agents in Photoacoustic Imaging: An In Vivo Review for Tumor Imaging. | Nanomaterials (Basel) | 2022 | https://conductscience.org/library/papers/35159738 | PubMed |
| 33510726 | Recent Advances in a Polydopamine-Mediated Antimicrobial Adhesion System. | Front Microbiol | 2020 | https://conductscience.org/library/papers/33510726 | PubMed |
| 33401518 | Melanin-Like Nanomedicine in Photothermal Therapy Applications. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33401518 | PubMed |
| 33134253 | pH-Triggered Assembly of Natural Melanin Nanoparticles for Enhanced PET Imaging. | Front Chem | 2020 | https://conductscience.org/library/papers/33134253 | PubMed |
| 32756369 | Melanin and Melanin-Like Hybrid Materials in Regenerative Medicine. | Nanomaterials (Basel) | 2020 | https://conductscience.org/library/papers/32756369 | PubMed |
| 32574686 | 64Cu-labeled melanin nanoparticles for PET/CT and radionuclide therapy of tumor. | Nanomedicine | 2020 | https://conductscience.org/library/papers/32574686 | PubMed |
| 31827881 | Recent advances in melanin-like nanomaterials in biomedical applications: a mini review. | Biomater Res | 2019 | https://conductscience.org/library/papers/31827881 | PubMed |
| 29761997 | [Research progress on characteristics and applications of melanin nanoparticles]. | Sheng Wu Yi Xue Gong Cheng Xue Za Zhi | 2017 | https://conductscience.org/library/papers/29761997 | PubMed |
| 28783106 | Melanin-Based Contrast Agents for Biomedical Optoacoustic Imaging and Theranostic Applications. | Int J Mol Sci | 2017 | https://conductscience.org/library/papers/28783106 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28595014
GET https://conductscience.org/api/papers/v1/28595014/authors